PFIZER
Large Cap BSE: 500680 NSE: PFIZER
₹4599.4
38.8 (0.85%)
  • Advice
  • Hold
As on 01 December, 2022 | 06:18

Pfizer Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in PFIZER

Start SIP

Pfizer Share Price

Pfizer Share Returns

  • Over 1 Month 5.5%
  • Over 3 Month 9.8%
  • Over 6 Month 7.58%
  • Over 1 Year -11.49%

Pfizer Key Statistics

P/E Ratio 34.3
PEG Ratio 7
Market Cap Cr 21,041
Price to Book Ratio 7.3
EPS 133.7
Dividend 1.4
Relative Strength Index 64.64
Money Flow Index 78.76
MACD Signal 28.74
Average True Range 90.47

Pfizer Investment Rating

  • Master Rating:
  • Pfizer (Nse) has an operating revenue of Rs. 2,455.93 Cr. on a trailing 12-month basis. An annual revenue growth of 15% is outstanding, Pre-tax margin of 30% is great, ROE of 21% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 6% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 77 which is a FAIR score but needs to improve its earnings, a RS Rating of 47 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 124 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Pfizer Financials
IndicatorSep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 637593550676636749535
Operating Expenses Qtr Cr 406401384481447463409
Operating Profit Qtr Cr 232192165195189286126
Depreciation Qtr Cr 26273427272727
Interest Qtr Cr 3442224
Tax Qtr Cr 104111940326932
Net Profit Qtr Cr 31133126144143200101

Pfizer Technicals

EMA & SMA

Current Price
4599.4
38.8 (0.85%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 4455.73
  • 50 Day
  • 4391.25
  • 100 Day
  • 4343.06
  • 200 Day
  • 4300.01
  • 20 Day
  • 4456.92
  • 50 Day
  • 4373.81
  • 100 Day
  • 4290.16
  • 200 Day
  • 4297.31

Pfizer Resistance and Support

PIVOT
₹4543.2
Resistance
First Resistance 4611.4
Second Resistance 4662.2
Third Resistance 4730.4
RSI 64.64
MFI 78.77
MACD Single Line 28.74
MACD 39.91
Support
First Resistance 4492.4
Second Resistance 4424.2
Third Resistance 4373.4

Pfizer Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 16,679 979,558 58.73
Week 16,746 985,693 58.86
1 Month 22,121 1,360,858 61.52
6 Month 20,469 1,375,542 67.2

Pfizer Result Highlights

Pfizer Synopsis

NSE-Medical-Diversified

Pfizer Ltd. is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 2610.99 Cr. and Equity Capital is Rs. 45.75 Cr. for the Year ended 31/03/2022. Pfizer Ltd. is a Public Limited Listed company incorporated on 21/11/1950 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24231MH1950PLC008311 and registration number is 008311.
Market Cap 21,041
Sales 2,456
Shares in Float 1.65
No of funds 116
Yield 0.76
Book Value 7.35
U/D Vol ratio 1.6
LTDebt / Equity
Alpha -0.05
Beta 0.48

Pfizer

Owner NameSep-22Jun-22Mar-22Dec-21
Promoters 63.92%63.92%63.92%
Mutual Funds 6.51%7.17%7.94%
Insurance Companies 8.32%0.73%0.61%
Foreign Portfolio Investors 2.55%2.55%2.2%
Financial Institutions/ Banks 0.02%0.02%0.02%
Individual Investors 13.94%14.09%14.19%
Others 4.74%11.52%11.12%

Pfizer Management

Name Designation
Mr. S Sridhar Managing Director
Mr. Milind Patil Executive Director (Finance) & CFO
Mr. Samir Kazi Executive Director
Mr. Sunil Lalbhai Independent Director
Mr. Pradip Shah Chairman & Ind.Director
Mr. Uday Khanna Independent Director
Ms. Meena Ganesh Independent Director

Pfizer Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Pfizer Corporate Action

Date Purpose Remarks
2022-11-11 Quarterly Results
2022-08-05 Quarterly Results
2022-05-20 Audited Results & Dividend
2022-02-03 Quarterly Results
2021-11-03 Quarterly Results
Date Purpose Remarks
2022-09-20 SPECIAL Rs.30.00 per share (300%) Special Interim Dividend
2022-08-19 FINAL Rs.35.00 per share(350%)Dividend

Pfizer MF Shareholding

Name Amount(cr)
Nippon India Small Cap Fund - Growth 22844
Nippon India Multi Cap Fund - Growth 14025
Aditya Birla Sun Life Tax Relief 96 Pyt of Inc Dis cum Cap Wdrl 13944
Nippon India Large Cap Fund - Growth 12534
DSP Tax Saver Fund Regular Plan Growth 10428

Pfizer FAQs

What is Share Price of Pfizer ?

Pfizer share price is ₹4599 As on 01 December, 2022 | 06:04

What is the Market Cap of Pfizer ?

The Market Cap of Pfizer is ₹21041.2 Cr As on 01 December, 2022 | 06:04

What is the P/E ratio of Pfizer ?

The P/E ratio of Pfizer is 34.3 As on 01 December, 2022 | 06:04

What is the PB ratio of Pfizer ?

The PB ratio of Pfizer is 7.3 As on 01 December, 2022 | 06:04

Q2FY23